Aditya Agarwal

Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response

J. Andrews, I. Lawrance, A. Sechi, 2015, Internal medicine journal.